Current Preprints

  • Meneghetti M, Gudmundsen F, Jessen NS, Sui K, Baun C, Palner M*, Markos C*. Mapping whole brain effects of infrared neural stimulation with positron emission tomography, 2023. bioRxiv 2022.12.24.521746.

https://doi.org/10.1101/2022.12.24.521746

*Shared senior authorship


Peer-Reviewed Publications

2023

Cameron LP, Benetatos J, Lewis V, Bonniwell EM, Jaster AM, Moliner R, Castrén E, McCorvy JD, Palner M, Aguilar-Valles A. Beyond the 5-HT2A Receptor: Classic and Nonclassic Targets of Psychedelic Drug Action, Journal of Neuroscience, 2023

Kiilerich KF, Lorenz J, Scharff MB, Speth N, Xiong M, Jessen NS, … Palner M. Repeated low doses of psilocybin increase resilience to stress, lower compulsive actions, and strengthen cortical connections to the paraventricular thalamic nucleus in rats, Molecular Psychiatry, 2023.

Egger K, Gudmundsen F, Jessen NS, Baun C, Pötzsch S, Shalgunov V, … Palner M. Pharmacokinetic and Pharmacodynamic Interaction of the Ayahuasca Constituents Harmine and Dimethyltryptamine (DMT) in the Rat Brain, Frontiers of Neuropharmacology, 2023.


2022

Casado-Sainz A, Gudmundsen F, Baerentzen SL, Lange D, Ringsted A, Martinez-Tajada I, Medina S, Lee H, Svarer C, Keller SH, Schain M, Kjaerby C, Fisher PM, Cumming P, Palner M. Dorsal striatal dopamine induces fronto-cortical hypoactivity and attenuates anxiety and compulsive behaviors in rats, Neuropsychopharmacology, 2022, 47(2) 454-464

Zhao X, Meyers KT, Marballi KK, Maple AM, Kang P, Palner, M, Overgaard A, Gallitano AL. Environment rapidly upregulates serotonin 2A receptor expression via immediate early gene Egr3. Molecular Psychiatry, 2022, 27(3).


2021

Raval NR, Gudmundsen F, Videbæk A, Petersen IN, Mikkelsen JD, Plavén-Sigray P, Fisher PM, Knudsen GM, Palner M. Synaptic density and neuronal metabolic function measured by PET in the unilateral 6-OHDA rat model of Parkinson’s disease, Accepted Frontiers of Synaptic Neuroscience, 2021 (13),

Cumming P, Scheidegger M, Dornbierer D, Palner M, Quednow BB, Martin-Soelch C. Molecular and functional imaging studies of hallucinogenic drug action in animals and humans. Molecules, 2021, 26 (9).

Breusova K, Ernstsen KG, Palner M, Linnet K, Kristensen JL, Kretschmann AC. A quantitative method for the selective 5-HT2A agonist 25CN-NBOH in rat plasma and brain. Journal of Pharmaceutical and Biomedical Analysis, 2021, 114016

Jacobsen SC, Speth NR, Xiong M, Herth MM, Kristensen JL, Palner M, Janfelt C. Desorption Electrospray Ionization Mass Spectrometry Imaging of Cimbi-36, a 5-HT 2A Receptor Agonist, with Direct Comparison to Autoradiography and Positron Emission Tomography. Molecular Imaging and Biology, 2021.


2020

Shalgunov V, Xiong M, L’Estrade ET, Raval NR, Andersen IV, Edgar FG, Speth NR, Baerentzen SL, Hansen HD, Donovan LL, Nasser A, Peitersen ST, Kjaer A, Knudsen GM, Syvänen S, Palner M, Herth MM. Blocking of efflux transporters in rats improves translational validation of brain radioligands. EJNMMI research, 2020, 10 (1), 1-11

Jensen AA, Halberstadt AL, Märcher-Rørsted E, Odland AU, Chatha M, Speth N, Liebscher G, Hansen M, Bräuner-Osborne H, Palner M, Andreasen JT, Kristensen JL. The selective 5-HT2A receptor agonist 25CN-NBOH: structure-activity relationship, in vivo pharmacology, and in vitro and ex vivo binding characteristics of [3H] 25CN-NBOH. Biochem. Parmacol, 2020, 177:113979.


These are papers related to the Palner Lab, for a complete list of papers by Mikael Palner please see his ORCID